secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001822462-25-000007
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics releases September 2025 investor presentation without new material disclosures
--------------------------------------------------------------------------------

- Presentation reiterates company focus on unique biology, precision therapeutics, and broad impact.
- No new financial, clinical, or strategic data provided in the filing excerpt.
- Intended for use in investor meetings; no guidance or material events announced.
- Stock ticker FHTX listed on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000182246225000007/0001822462-25-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000182246225000007/fhtx-20250902.htm
  HTML page:      https://secwatch.observer/filing/0001822462-25-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer